<DOC>
	<DOCNO>NCT01293825</DOCNO>
	<brief_summary>Psychotropic-related weight gain common concern among patient bipolar disorder ( BD ) . This concern affect individual 's satisfaction treatment may lead reduce adherence illness relapse . Patient-focused care attentive patient concern time utilize evidence-based treatment . Ziprasidone currently FDA approve maintenance treatment BD . Ziprasidone may associate less weight gain compare alternative BD maintenance treatment . The propose project evaluate switch ziprasidone may affect patient adherence , drug attitude , satisfaction care clinical outcome ( psychiatric symptom , functional status , weight ) among BD patient concerned weight gain .</brief_summary>
	<brief_title>Ziprasidone Switching Response Adherence Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder ( Zip Ad )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Psychotropic Drugs</mesh_term>
	<criteria>1 . Diagnosis Type I II BD least 6 month ( confirm MINI ) 2 . On maintenance evidencebased treatment BD ( lithium , antipsychotic , anticonvulsant ) 3 . Have weight gain concern individual believe related BD medication treatment 4 . Suboptimal adherence measure Tablet Routines Questionnaire ( TRQ ) patient feel relate weight gain concern . TRQ threshold define miss average 20 % prescribed BD treatment last week month miss 20 % `` offending agent '' last week last month . This consistent methodology PIs previous BD adherence study 1 . Known resistance intolerance ziprasidone 2 . Medical contraindication ziprasidone 3 . Individuals ziprasidone immediately prior study enrollment 4 . Prior current treatment clozapine 5 . Diagnosis eat disorder 6 . Individuals whose suboptimal adherence relate inability pay BD medication treatment inability arrange transportation BD treatment clinical visit 7 . Concurrent medical condition psychiatric illness , opinion research psychiatrist , would interfere patient 's ability participate trial 8 . Current substance dependence 9 . High risk harm self others 10 . Female currently pregnant breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>